Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Advances of Fully Biodegradable Poly-p-Dioxanone and Polylactic Acid-Based Polymers as Left Atrial Appendage Closure Devices.

Created on 21 Aug 2026

Authors

Qingyong Chen, Huina He, Qiang Peng

Published in

Macromolecular bioscience. Volume 26. Issue 8. Pages e70246.

Abstract

Atrial fibrillation (AF)-related ischemic stroke carries substantial clinical risks, and transcatheter left atrial appendage closure (LAAC) constitutes a core stroke preventive intervention. Conventional non-degradable occluders are hampered by permanent foreign body retention, insufficient anatomical conformability, and sustained long-term foreign-body inflammatory stimulation. Fully biodegradable materials offer a novel approach for device advancement. This review summarizes the characteristics and composite modification technologies of poly-p-dioxanone (PPDO) and polylactic acid (PLA), analyzes the application advantages and latest research progress of biodegradable closure devices, discusses technical challenges and corresponding solutions, and prospects their development trends toward multi-functionality and intellectualization. Owing to their intrinsic advantages of complete in vivo resorption and tunable mechanical/degradation properties, such composites are poised to emerge as the next-generation mainstream LAAC implants, advancing AF-associated stroke prophylaxis toward precise, biointegrated interventional therapy.

PMID:
42625128
Bibliographic data and abstract were imported from PubMed on 21 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement